{"gene":"DGKD","run_date":"2026-04-28T17:46:02","timeline":{"discoveries":[{"year":1996,"finding":"DGKδ was cloned and identified as a diacylglycerol kinase with a pleckstrin homology (PH) domain, two cysteine-rich zinc finger-like (C1) structures, a C-terminal SAM-like tail similar to EPH receptor tyrosine kinases, and a long Glu/Ser-rich insertion. Increased DGK activity was detected in the particulate fraction of COS-7 cells expressing transfected DGKδ cDNA, independent of phosphatidylserine activation.","method":"cDNA cloning, transfection in COS-7 cells, DGK activity assay, Northern blot","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — original biochemical characterization with direct enzyme activity assay in transfected cells","pmids":["8626538"],"is_preprint":false},{"year":2002,"finding":"Alternative splicing of human DGKD generates two isoforms (DGKδ1, 130 kDa; DGKδ2, 135 kDa) with distinct expression patterns and regulatory functions. DGKδ1 translocates from cytoplasm to plasma membrane via its PH domain in response to phorbol ester, whereas DGKδ2 remains cytoplasmic due to its N-terminal extension blocking translocation. The two isoforms form homo- and hetero-oligomers detected by co-immunoprecipitation.","method":"RT-PCR, phorbol ester stimulation, co-immunoprecipitation, subcellular fractionation, live cell imaging","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (co-IP, translocation assay, expression analysis) in single rigorous study","pmids":["12200442"],"is_preprint":false},{"year":2002,"finding":"DGKδ suppresses anterograde ER-to-Golgi transport via its SAM domain (acting as ER-targeting motif) and PH domain, without requiring kinase activity. DGKδ expression caused redistribution of Golgi and VTC marker proteins to the ER, delayed VSV-G transport, and abrogated COPII-coated structure formation (Sec13p-labeled) without affecting COPI retrograde structures.","method":"NIH3T3 cell expression, live imaging of VSV-G trafficking, BFA washout assay, kinase-dead mutant analysis, COPII/COPI marker immunostaining","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal experiments including kinase-dead mutants and domain dissection with defined trafficking phenotype","pmids":["11809841"],"is_preprint":false},{"year":2002,"finding":"DGKδ forms homo-oligomeric structures via its SAM domain in intact cells; phorbol ester stimulation induces PKC-dependent phosphorylation of DGKδ, dissociation of oligomers, and translocation from cytoplasmic vesicles to the plasma membrane. SAM-domain mutants unable to self-associate constitutively localize to the plasma membrane.","method":"Yeast two-hybrid, bacterially expressed SAM domain gel filtration, co-immunoprecipitation, phorbol ester stimulation, PKC inhibitor (staurosporine) treatment, subcellular fractionation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (yeast 2-hybrid, gel filtration, co-IP, mutant analysis) with functional translocation readout","pmids":["12084710"],"is_preprint":false},{"year":2006,"finding":"DGKδ deficiency in mice causes DAG accumulation, increased PKC-mediated threonine phosphorylation of EGFR, reduced EGFR protein expression and activity, and enhanced phosphorylation of other PKC substrates. DGKδ knockout pups phenocopy EGFR knockout mice (open eyelids, neonatal lethality), establishing DGKδ as a regulator of PKC-EGFR signaling.","method":"Gene knockout in mice, Western blot for phospho-EGFR and PKC substrates, DAG measurement, phenotypic analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — genetic knockout with defined molecular and phenotypic readouts, replicated in multiple tissues","pmids":["17021016"],"is_preprint":false},{"year":2007,"finding":"Short-term high glucose exposure transiently redistributes DGKδ from cytoplasm to plasma membrane in L6 myotubes, activating DGK activity and reducing intracellular DAG and PKCα activity, thereby transactivating insulin receptor signaling and GLUT4 translocation. Antisense silencing of DGKδ (but not DGKα) prevented these effects, establishing DGKδ as the mediator of glucose-induced acute DGK activation in skeletal muscle.","method":"L6 myotube antisense silencing, DGK inhibitor (R59949), subcellular fractionation, PKCα activity assay, insulin receptor phosphorylation, GLUT4 translocation imaging","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — isoform-specific silencing with multiple orthogonal readouts establishing pathway position","pmids":["17675299"],"is_preprint":false},{"year":2008,"finding":"Reduced DGKδ expression and DGK activity were found in skeletal muscle of type 2 diabetic patients. DGKδ haploinsufficiency in mice increased DAG content, reduced peripheral insulin sensitivity, impaired insulin signaling and glucose transport, and caused age-dependent obesity and metabolic inflexibility, establishing DGKδ as a contributor to hyperglycemia-induced peripheral insulin resistance.","method":"Human skeletal muscle biopsies (T2D patients vs controls), DGKδ haploinsufficient mouse model, DAG measurement, insulin tolerance test, glucose transport assay, metabolic cage studies","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — human tissue data combined with genetic mouse model with multiple metabolic readouts; highly cited foundational study","pmids":["18267070"],"is_preprint":false},{"year":2008,"finding":"DGKδ2 binds to AP2α (adaptor protein 2 alpha) via DXF-type motifs (F369DTFRIL and D746PF) in the catalytic domain, interacting with the AP2α ear platform subdomain. This interaction, together with DGK kinase activity, is required for clathrin-dependent endocytosis (transferrin internalization). Mutants lacking AP2α binding or kinase activity failed to rescue endocytosis impaired by DGKδ siRNA knockdown.","method":"Co-immunoprecipitation, domain mapping, transferrin/EGF uptake assay, siRNA knockdown, overexpression of wild-type and mutant DGKδ2","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 2 — binding domain mapping with functional rescue assay requiring both binding and catalytic activity","pmids":["17880279"],"is_preprint":false},{"year":2009,"finding":"DGKδ interacts with RACK1 (receptor for activated C kinase 1) via WD40 repeats 5–7 of RACK1. Co-immunoprecipitation confirmed selective interaction of RACK1 with DGKδ but not type I DGKs in mammalian cells. The interaction is regulated by phorbol ester and DGKδ recruits RACK1 to clathrin-coated vesicles.","method":"Yeast two-hybrid screen, co-immunoprecipitation in COS-7 cells, phorbol ester treatment, colocalization imaging","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 3 — yeast 2-hybrid confirmed by co-IP, functional consequence inferred from localization","pmids":["19416640"],"is_preprint":false},{"year":2010,"finding":"DGKδ deficiency leads to enhanced ubiquitination of EGFR and reduced expression of deubiquitinase USP8, promoting EGFR degradation. This is mediated through excessive PKCα activity (due to DAG accumulation) inhibiting Akt, which normally stabilizes USP8. Depletion of PKCα or PHLPP2 rescued USP8 levels and normalized EGFR degradation in DGKδ-deficient cells.","method":"DGKδ knockout MEFs, siRNA knockdown of PKCα/PHLPP2, ubiquitination assay, Western blot for USP8/EGFR/Akt","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — genetic KO plus rescue experiments with multiple epistasis steps demonstrating pathway","pmids":["20064931"],"is_preprint":false},{"year":2010,"finding":"The SAM domain of DGKδ1 binds zinc at multiple sites, driving formation of large sheets of helical polymers. Zinc-binding is required for cytoplasmic puncta formation and regulation of plasma membrane transport; a SAM domain mutant refractory to zinc binding showed diminished puncta, partially impaired plasma membrane transport regulation, and lost ability to inhibit COPII vesicle formation.","method":"Biochemical zinc-binding assay, gel filtration, electron microscopy of SAM polymer sheets, DGKδ SAM zinc-binding mutant, live cell imaging of puncta, COPII vesicle formation assay","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution of zinc-driven SAM oligomerization combined with mutagenesis and cellular functional assays","pmids":["20857926"],"is_preprint":false},{"year":2012,"finding":"DGKδ deficiency reduces Akt phosphorylation downstream of three receptor tyrosine kinases via a pathway involving excessive PKCα activity promoting Akt dephosphorylation through PHLPP2, with β-arrestin 1 acting as scaffold for PHLPP2 and Akt1. Depletion of PKCα or PHLPP2 (but not PHLPP1) rescued Akt phosphorylation in DGKδ-deficient cells. DGKδ deficiency also reduced cell proliferation and migration and enhanced apoptosis.","method":"DGKδ knockout cells, siRNA knockdown of PKCα/PHLPP1/PHLPP2/β-arrestin 1, phospho-Akt Western blot, cell proliferation and migration assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple epistasis knockdown experiments defining precise pathway order with multiple orthogonal readouts","pmids":["23184957"],"is_preprint":false},{"year":2012,"finding":"DGKδ1, but not DGKδ2 or DGKη1/2, translocates from cytoplasm to plasma membrane within 5 min in response to high glucose. This translocation is dependent on PI3K signaling and requires both PH and C1 domains; the SAM domain negatively regulates this translocation.","method":"HEK293 and C2C12 cell imaging, PI3K inhibitor (LY294002, GDC-0941) treatment, domain deletion mutants, high glucose stimulation","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 2 — domain dissection with pharmacological inhibition and multiple isoform controls establishing isoform-specific mechanism","pmids":["22974639"],"is_preprint":false},{"year":2014,"finding":"DGKδ preferentially phosphorylates palmitic acid (16:0)-containing diacylglycerol species (30:0-, 32:0-, 34:0-PA and related monounsaturated species) in high glucose-stimulated C2C12 myoblasts. These DG substrates are supplied via the phosphatidylcholine-specific phospholipase C (PC-PLC) pathway, not from phosphatidylinositol turnover-derived 20:4-DG. PC-PLC was co-immunoprecipitated with DGKδ2.","method":"LC-MS analysis of PA species, DGKδ-specific siRNA knockdown, DGKδ2 overexpression, PC-PLC inhibitor D609, co-immunoprecipitation of PC-PLC with DGKδ2","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — LC-MS/MS substrate identification combined with siRNA, overexpression, inhibitor, and co-IP approaches","pmids":["25112873"],"is_preprint":false},{"year":2015,"finding":"DGKδ deficiency impairs AMPK activation and signaling in skeletal muscle, concomitant with impaired lipid oxidation and elevated incorporation of free fatty acids into triglycerides. DGKδ(+/-) mice also showed reduced voluntary running and impaired force production and relaxation dynamics during repeated contractions.","method":"DGKδ haploinsufficient mice, AMPK phosphorylation assay, lipid oxidation measurement, fatty acid incorporation assay, voluntary wheel running, ex vivo muscle contraction","journal":"American journal of physiology. Endocrinology and metabolism","confidence":"High","confidence_rationale":"Tier 2 — genetic model with multiple biochemical and physiological readouts","pmids":["26530149"],"is_preprint":false},{"year":2016,"finding":"Brain-specific DGKδ knockout mice exhibit OCD-like behaviors (compulsive checking in novel object recognition, increased marble burying) alleviated by the serotonin reuptake inhibitor fluoxetine. DGKδ deficiency increases axon/neurite outgrowth in primary cortical neurons and DGKδ-knockdown neuroblastoma cells, while DGKδ overexpression decreases neurite number.","method":"Brain-specific conditional DGKδ KO mice, behavioral tests (novel object recognition, marble burying), fluoxetine pharmacological rescue, primary neuron and Neuro-2a cell morphology analysis","journal":"Brain research","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with behavioral phenotype and pharmacological rescue, plus cellular mechanistic data","pmids":["27423518"],"is_preprint":false},{"year":2017,"finding":"DGKδ is a residential lipid kinase in the ER that triggers release of IFT88-containing COPII-coated vesicles from ER exit sites (ERES) for delivery to primary cilia. IFT88 physically interacts with DGKδ. DGKδ is required for Sonic hedgehog (Shh) signal transduction both in vitro and in vivo.","method":"Co-immunoprecipitation of IFT88 with DGKδ, RNAi silencing and gene KO, COPII vesicle formation assay, Shh signaling reporter assay, primary cilia formation imaging","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 — physical interaction combined with KO/KD functional assays establishing pathway role in ciliogenesis and Shh signaling","pmids":["28706295"],"is_preprint":false},{"year":2018,"finding":"DGKδ deficiency in the brain increases SERT protein levels in the cerebral cortex, and DGKδ physically interacts and co-localizes with SERT. DGKδ-KO also decreases tryptophan hydroxylase-2 expression, increases monoamine oxidase-A expression, and reduces serotonin levels in the cerebral cortex, indicating comprehensive serotonergic hypofunction.","method":"Brain-specific DGKδ KO mice, Western blot for SERT/TPH2/MAO-A, serotonin ELISA, co-immunoprecipitation/colocalization of DGKδ and SERT","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 2 — genetic KO combined with physical interaction data and multiple serotonergic pathway readouts","pmids":["29486157"],"is_preprint":false},{"year":2018,"finding":"DGKδ controls cyclin D1 downregulation during C2C12 myogenic differentiation by attenuating PKC signaling. DGKδ knockdown increased cyclin D1 expression and phospho-PKC (conventional and novel isoforms) while decreasing myogenin expression and myosin heavy chain-positive cell number.","method":"C2C12 myogenic differentiation model, DGKδ-specific siRNA, Western blot for cyclin D1/myogenin/MHC/phospho-PKC, MHC immunofluorescence","journal":"Biochimie","confidence":"Medium","confidence_rationale":"Tier 2 — KD with multiple molecular readouts but single lab, no rescue experiment","pmids":["29859210"],"is_preprint":false},{"year":2019,"finding":"DGKδ interacts with MAGE-D1 adaptor protein and Praja-1 E3 ubiquitin-protein ligase. DGKδ catalytic subdomain-a and coiled-coil region interact with the C-terminal cytoplasmic region of SERT. DGKδ promotes SERT ubiquitination through Praja-1 and induces SERT degradation via the ubiquitin-proteasome system in a DGKδ catalytic activity-dependent manner.","method":"Co-immunoprecipitation, domain mapping, overexpression/knockdown in cells, proteasome inhibitor MG-132, ubiquitination assay","journal":"Biochimica et biophysica acta. Molecular and cell biology of lipids","confidence":"High","confidence_rationale":"Tier 2 — physical interaction with domain mapping, functional ubiquitination assay, pharmacological validation, and catalytic activity-dependence demonstrated","pmids":["31891772"],"is_preprint":false},{"year":2019,"finding":"DGKD knockdown in vitro impairs calcium-sensing receptor (CaSR) signal transduction, an effect rectified by the calcimimetic cinacalcet, placing DGKδ as a component of CaSR signaling and linking it to urinary calcium excretion.","method":"siRNA knockdown of DGKD in cells, CaSR signaling assay, cinacalcet rescue, GWAS and validation cohort correlation with urinary calcium","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro KD with pharmacological rescue establishing DGKδ in CaSR pathway, supported by genetic association","pmids":["31729369"],"is_preprint":false},{"year":2020,"finding":"DGKδ selectively phosphorylates 18:0/22:6-DG to generate 18:0/22:6-phosphatidic acid (PA) in the brain. 18:0/22:6-PA selectively binds to and enhances the E3 ubiquitin ligase activity of Praja-1, mechanistically linking DGKδ-generated PA species to SERT degradation.","method":"DGKδ-KO mouse brain lipidomic profiling (LC-MS), lipid-protein binding assay, Praja-1 activity assay with specific PA species","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 — in vivo substrate identification by KO lipidomics combined with in vitro enzymatic activity assay demonstrating PA species selectivity","pmids":["32134507"],"is_preprint":false},{"year":2020,"finding":"DGKδ interacts with sphingomyelin synthase-related protein (SMSr) through their respective SAM domains. SMSr overexpression enhances production of 16:0- or 16:1-containing PA species in DGKδ-overexpressing cells, and SMSr enhances DGKδ activity via their SAMDs in vitro, establishing SMSr as an upstream DG-providing enzyme for DGKδ.","method":"Co-immunoprecipitation of full-length and SAM domain deletion mutants, LC-MS/MS of PA species, in vitro DGKδ activity assay with SMSr","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro enzymatic activation assay combined with domain-mapping co-IP and quantitative lipidomics","pmids":["31980461"],"is_preprint":false},{"year":2021,"finding":"β-cell-specific DGKδ knockout mice showed lower blood glucose, higher insulin, better glucose tolerance, increased Ki-67-positive islet cells, and elevated cyclin B1 expression, demonstrating DGKδ functions as a proliferation suppressor in pancreatic β-cells. DGKδ knockdown in MIN6 cells also increased BrdU incorporation and cyclin B1 expression.","method":"β-cell-specific DGKδ KO mice, glucose tolerance tests, Ki-67/BrdU proliferation assays, cyclin B1 Western blot, streptozotocin model","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific KO with multiple proliferation and metabolic readouts validated in cell line","pmids":["33774855"],"is_preprint":false},{"year":2024,"finding":"USP11 (ubiquitin-specific peptidase 11) physically interacts with DGKδ via USP11 catalytic domain 1 region and DGKδ C1 domains/catalytic subdomain-a. USP11 deubiquitinates and stabilizes DGKδ protein; USP11 inhibition or knockdown increases DGKδ ubiquitination and decreases DGKδ protein levels, impairing cellular glucose uptake.","method":"DGKδ interactome analysis, co-immunoprecipitation, domain mapping, USP11 inhibitor (mitoxantrone), siRNA knockdown, ubiquitination assay, glucose uptake assay","journal":"Biochimica et biophysica acta. Molecular cell research","confidence":"High","confidence_rationale":"Tier 2 — interactome-based discovery confirmed by domain mapping, pharmacological and genetic KD, ubiquitination assay, and functional readout","pmids":["39603461"],"is_preprint":false},{"year":2024,"finding":"Myf5-promoter-driven conditional DGKδ knockout mice showed reduced body weight, decreased skeletal muscle mass, and reduced myofiber thickness. Cardiotoxin-induced muscle injury revealed that DGKδ is strongly upregulated in myogenin-positive satellite cells, and DGKδ deficiency impaired myofiber formation, myogenic marker expression (embryonic myosin heavy chain, myogenin), and satellite cell-mediated muscle regeneration.","method":"Conditional Myf5-Cre DGKδ KO mice, cardiotoxin injury model, immunofluorescence for satellite cell markers, Western blot for myogenic differentiation markers, histological analysis","journal":"FASEB bioAdvances","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with injury model establishing DGKδ role in satellite cell-mediated regeneration with molecular markers","pmids":["39781426"],"is_preprint":false},{"year":2025,"finding":"Reduced DGKδ expression and KSD-associated DGKD missense variants impair CaSR signal transduction in vitro, demonstrable with cellular assays, and this impairment is ameliorated by cinacalcet (positive CaSR allosteric modulator), further confirming DGKδ as a functional partner of CaSR signaling.","method":"siRNA knockdown and missense variant overexpression in cells, CaSR signaling assay, cinacalcet pharmacological rescue","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 — KD plus variant functional study with pharmacological rescue; extends prior work from PMID 31729369","pmids":["40372791"],"is_preprint":false},{"year":2025,"finding":"PHOSPHO1, a cytosolic protein, exhibits D609-sensitive PC-PLC and PE-PLC activities and its overexpression increases saturated/monounsaturated fatty acid-containing DG levels in HEK293 cells. PHOSPHO1 co-sediments and co-localizes with DGKδ, identifying it as a candidate cytosolic DG-generating enzyme upstream of DGKδ.","method":"In vitro enzyme activity assay of purified PHOSPHO1 with PC/PE substrates, D609 inhibitor, DG species quantification by LC-MS in overexpressing cells, co-sedimentation and colocalization with DGKδ","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 1 for PHOSPHO1 enzymatic activity; Tier 3 for DGKδ interaction (co-sedimentation only); overall Medium","pmids":["39992810"],"is_preprint":false},{"year":2013,"finding":"DGKδ promotes lipogenesis: DGKδ expression is markedly increased during 3T3-L1 adipocyte differentiation, DGKδ transfection increases triglyceride synthesis, and DGKδ knockout MEFs show reduced synthesis of neutral and polar lipids, particularly those with shorter acyl chains, and lower expression of acetyl-CoA carboxylase, fatty acid synthase, and activation of ATP citrate lyase.","method":"3T3-L1 differentiation assay, DGKδ transfection, DGKδ KO MEFs, glycerol incorporation assay, lipidomics, Western blot for lipogenic enzymes","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 2 — gain- and loss-of-function with lipidomics and enzyme expression data in multiple cell systems","pmids":["24090246"],"is_preprint":false},{"year":2019,"finding":"Creatine kinase muscle type (CKM) specifically binds 16:0/16:0-PA and other saturated/monounsaturated fatty acid-containing PA species (but not PUFA-containing PAs, and not other phospholipids) with high affinity (Kd ~2.0 μM), identifying CKM as a selective downstream target of DGKδ-produced PA species in skeletal muscle.","method":"Protein pulldown from mouse skeletal muscle, lipid-protein binding assay with defined PA species, dissociation constant measurement","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 — in vitro binding assay with lipid selectivity characterization, no functional readout of CKM activation by DGKδ-PA","pmids":["31010675"],"is_preprint":false}],"current_model":"DGKδ is a lipid kinase that phosphorylates diacylglycerol (preferentially saturated/monounsaturated fatty acid-containing DG species supplied by the PC-PLC/SMSr/PHOSPHO1 pathway rather than PI-turnover-derived 18:0/20:4-DG) to generate phosphatidic acid, thereby terminating DAG-PKC signaling; it is regulated by SAM domain-mediated zinc-dependent oligomerization controlling its localization (cytoplasmic puncta vs. plasma membrane), interacts with AP2α to regulate clathrin-dependent endocytosis, with SERT/Praja-1 to promote ubiquitin-proteasome degradation of SERT via 18:0/22:6-PA, with IFT88 to trigger ER export of ciliary cargo, and with CaSR signaling components; its stability is maintained by USP11-mediated deubiquitination, and its deficiency impairs skeletal muscle insulin signaling, AMPK activation, myogenic differentiation, and regeneration, while its brain-specific loss causes serotonergic dysfunction and OCD-like behavior."},"narrative":{"teleology":[{"year":1996,"claim":"Establishing DGKδ as a new DAG kinase family member with a unique domain architecture (PH, C1, SAM) answered the question of whether additional DGK isoforms with distinct regulatory properties existed.","evidence":"cDNA cloning and DGK activity assay in transfected COS-7 cells","pmids":["8626538"],"confidence":"High","gaps":["Substrate specificity unknown","Physiological function not established","SAM domain function not determined"]},{"year":2002,"claim":"Discovery that alternative splicing generates two isoforms with distinct translocation behaviors, and that the SAM domain drives zinc-dependent homo-oligomerization controlling cytoplasm-to-membrane redistribution, established the core regulatory logic of DGKδ activation.","evidence":"Co-IP of isoform oligomers, phorbol ester-induced translocation imaging, yeast two-hybrid and gel filtration of SAM domain, domain deletion mutants in NIH3T3/COS-7 cells","pmids":["12200442","12084710","11809841"],"confidence":"High","gaps":["Zinc-binding stoichiometry and structural basis of SAM polymers not resolved","Whether kinase activity is required for all trafficking functions unclear"]},{"year":2006,"claim":"Genetic ablation in mice revealed that DGKδ is essential for restraining DAG-PKC signaling in vivo, as knockout caused DAG accumulation, hyperactive PKC-mediated EGFR threonine phosphorylation, and neonatal lethality phenocopying EGFR-null mice.","evidence":"DGKδ knockout mice with DAG measurement, phospho-EGFR Western blot, phenotypic analysis","pmids":["17021016"],"confidence":"High","gaps":["Tissue-specific contributions to lethality not dissected","Whether PA production or solely DAG clearance drives the phenotype not resolved"]},{"year":2008,"claim":"Two studies established DGKδ as a metabolic regulator: reduced expression in human type 2 diabetic muscle linked it to insulin resistance, haploinsufficient mice confirmed DAG-dependent impairment of insulin signaling and glucose transport, and AP2α binding coupled DGKδ kinase activity to clathrin-dependent endocytosis.","evidence":"Human skeletal muscle biopsies, DGKδ haploinsufficient mice with metabolic phenotyping, AP2α co-IP with domain mapping and transferrin uptake rescue","pmids":["18267070","17880279"],"confidence":"High","gaps":["Mechanism connecting DGKδ-PA to AP2α-dependent vesicle formation not defined","Whether insulin resistance is solely PKC-mediated or involves PA effectors unknown"]},{"year":2010,"claim":"Biochemical reconstitution showed the SAM domain forms zinc-driven helical polymer sheets, and epistasis experiments in KO cells defined the DGKδ→DAG→PKCα→PHLPP2→Akt→USP8→EGFR degradation pathway, answering how DGKδ loss destabilizes EGFR.","evidence":"Electron microscopy of SAM polymers, zinc-binding mutant functional assays, DGKδ-KO MEFs with siRNA epistasis for PKCα/PHLPP2/USP8","pmids":["20857926","20064931"],"confidence":"High","gaps":["Whether zinc-SAM polymers form in vivo not confirmed","PHLPP2-Akt-USP8 axis not validated in intact organisms"]},{"year":2012,"claim":"The PKCα-PHLPP2-Akt axis downstream of DGKδ was generalized beyond EGFR to three receptor tyrosine kinases, with β-arrestin 1 identified as the scaffold, and glucose-induced DGKδ1 translocation was shown to require PI3K and PH/C1 domains.","evidence":"DGKδ-KO cells with siRNA knockdown of PKCα/PHLPP1/PHLPP2/β-arrestin 1, PI3K inhibitor treatment and domain deletion mutants in HEK293/C2C12","pmids":["23184957","22974639"],"confidence":"High","gaps":["PI3K-dependent translocation mechanism (lipid product sensed by PH domain?) not molecularly defined","In vivo relevance of β-arrestin 1 scaffolding not tested"]},{"year":2014,"claim":"LC-MS lipidomics resolved DGKδ substrate specificity: it preferentially phosphorylates 16:0-containing DAG species derived from the PC-PLC pathway, not PI-turnover-derived arachidonoyl-DAG, fundamentally redefining DGKδ as a DAG kinase operating in a non-canonical lipid metabolic branch.","evidence":"LC-MS PA species analysis after DGKδ siRNA/overexpression in C2C12 myoblasts, PC-PLC inhibitor D609, co-IP of PC-PLC with DGKδ2","pmids":["25112873"],"confidence":"High","gaps":["Identity of the PC-PLC enzyme upstream of DGKδ not genetically confirmed","Whether substrate selectivity reflects DGKδ intrinsic preference or substrate availability unclear"]},{"year":2016,"claim":"Brain-specific knockout revealed that DGKδ regulates serotonergic tone and neuronal morphology, with loss causing OCD-like behavior rescued by fluoxetine and enhanced neurite outgrowth, expanding DGKδ function from metabolism to neuropsychiatric circuits.","evidence":"Brain-specific conditional KO mice with behavioral tests and pharmacological rescue, primary cortical neuron morphology analysis","pmids":["27423518"],"confidence":"High","gaps":["Which DAG/PA species mediate serotonergic effects not identified at this point","Circuit-level localization of DGKδ-dependent serotonin changes not mapped"]},{"year":2017,"claim":"DGKδ was identified as a residential ER kinase that physically interacts with IFT88 and triggers COPII-dependent ER export of ciliary cargo, linking lipid kinase activity to ciliogenesis and Sonic hedgehog signaling.","evidence":"Co-IP of IFT88 with DGKδ, RNAi/KO with COPII vesicle and Shh reporter assays","pmids":["28706295"],"confidence":"High","gaps":["How PA production at ERES promotes COPII vesicle budding mechanistically unresolved","Whether all ciliary cargo depends on DGKδ or only IFT88 not tested"]},{"year":2019,"claim":"The mechanism of DGKδ-dependent SERT regulation was fully delineated: DGKδ recruits the Praja-1 E3 ligase via MAGE-D1 to promote SERT ubiquitination and proteasomal degradation in a catalytic activity-dependent manner, explaining the serotonergic hypofunction in brain-specific knockouts.","evidence":"Co-IP and domain mapping of DGKδ-SERT-Praja-1 complex, ubiquitination assay with kinase-dead mutant and proteasome inhibitor MG-132","pmids":["31891772","29486157"],"confidence":"High","gaps":["In vivo validation that Praja-1 mediates SERT turnover in DGKδ-KO brain not performed","Quantitative contribution of SERT accumulation vs. reduced serotonin synthesis to behavioral phenotype not established"]},{"year":2020,"claim":"Two discoveries connected DGKδ to specific lipid-protein signaling codes: in brain, DGKδ selectively produces 18:0/22:6-PA which activates Praja-1; in the ER, SMSr provides 16:0-containing DAG substrates via SAM-domain-mediated interaction, establishing tissue-specific upstream supply chains.","evidence":"KO brain lipidomics by LC-MS with PA-Praja-1 binding/activity assay; SMSr-DGKδ co-IP with SAM domain mutants and in vitro DGK activity reconstitution","pmids":["32134507","31980461"],"confidence":"High","gaps":["Whether SMSr-DGKδ axis operates in skeletal muscle not tested","Structural basis of 18:0/22:6-PA recognition by Praja-1 unknown"]},{"year":2021,"claim":"β-cell-specific knockout showed DGKδ suppresses pancreatic β-cell proliferation via cyclin B1 regulation, revealing a tissue where DGKδ loss is beneficial (improved glucose tolerance), contrasting with its pro-insulin-signaling role in muscle.","evidence":"β-cell-specific DGKδ KO mice with glucose tolerance tests, Ki-67/BrdU proliferation assays, cyclin B1 Western blot","pmids":["33774855"],"confidence":"High","gaps":["Whether proliferation effect is DAG- or PA-mediated not determined","Long-term β-cell function and exhaustion risk not assessed"]},{"year":2024,"claim":"DGKδ protein stability was shown to be maintained by USP11 deubiquitinase, and conditional skeletal muscle knockout demonstrated DGKδ is required for satellite cell-mediated muscle regeneration and myofiber maintenance.","evidence":"USP11-DGKδ co-IP with domain mapping, ubiquitination assay ± USP11 inhibitor/siRNA, glucose uptake assay; Myf5-Cre DGKδ KO with cardiotoxin injury and myogenic marker analysis","pmids":["39603461","39781426"],"confidence":"High","gaps":["Whether USP11 regulates DGKδ in tissues beyond the tested cell lines unknown","Whether impaired regeneration is DAG/PKC-dependent or PA-dependent not tested"]},{"year":2025,"claim":"DGKD missense variants associated with kidney stone disease impair CaSR signaling, rescued by cinacalcet, and PHOSPHO1 was identified as a candidate cytosolic PC-PLC providing saturated DAG substrates for DGKδ.","evidence":"Variant overexpression with CaSR signaling assay and cinacalcet rescue; PHOSPHO1 enzymatic assay and co-sedimentation with DGKδ","pmids":["40372791","39992810"],"confidence":"Medium","gaps":["PHOSPHO1-DGKδ physical interaction not validated by reciprocal co-IP","Whether DGKD variants cause kidney stone disease through CaSR-independent mechanisms not excluded","PHOSPHO1 contribution to DGKδ substrate pool not tested genetically"]},{"year":null,"claim":"Key unresolved questions include the structural basis of DGKδ substrate selectivity for saturated/monounsaturated DAGs, how PA production at ER exit sites mechanistically promotes COPII vesicle budding, and the relative contributions of DAG clearance versus PA generation to each tissue-specific phenotype.","evidence":"","pmids":[],"confidence":"High","gaps":["No crystal or cryo-EM structure of DGKδ catalytic domain","No reconstituted system linking specific PA species to COPII coat assembly","Tissue-specific interactome not systematically mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,5,13,21,22]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[13,21,22]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[2,16]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,3,5,12]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[1,3]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[3,8]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[4,5,6,9,11,20,26]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[13,14,22,28]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[2,7,8,16]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[19,24]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[16,18,25]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[15,17]}],"complexes":[],"partners":["AP2A1","IFT88","SLC6A4","PJA1","MAGED1","USP11","GNB2L1","SAMD8"],"other_free_text":[]},"mechanistic_narrative":"DGKδ is a diacylglycerol kinase that phosphorylates saturated and monounsaturated fatty acid-containing diacylglycerol species—supplied by PC-PLC/SMSr/PHOSPHO1 pathways rather than PI-turnover—to generate phosphatidic acid, thereby terminating DAG-PKC signaling and producing bioactive PA species with distinct downstream effectors [PMID:25112873, PMID:31980461, PMID:32134507]. Its subcellular distribution is governed by SAM domain-mediated zinc-dependent oligomerization, which retains DGKδ in cytoplasmic puncta; PKC-dependent phosphorylation or PI3K-dependent signals dissociate oligomers and drive PH/C1 domain-dependent translocation to the plasma membrane, where it attenuates DAG-PKC signaling to sustain insulin receptor/Akt activity, regulate EGFR stability, support clathrin-dependent endocytosis via AP2α binding, and promote SERT ubiquitin-proteasomal degradation through Praja-1 activation by 18:0/22:6-PA [PMID:12084710, PMID:20857926, PMID:17021016, PMID:17880279, PMID:31891772]. As a residential ER lipid kinase, DGKδ also triggers COPII-dependent ER export of IFT88-containing vesicles required for ciliogenesis and Sonic hedgehog signaling [PMID:28706295]. Loss of DGKδ in mice causes tissue-specific phenotypes including peripheral insulin resistance with age-dependent obesity in skeletal muscle haploinsufficiency, impaired myogenic differentiation and satellite cell-mediated regeneration, β-cell hyperproliferation, serotonergic hypofunction with OCD-like behavior in brain-specific knockouts, and neonatal lethality phenocopying EGFR-null mice in full knockouts [PMID:18267070, PMID:39781426, PMID:33774855, PMID:27423518, PMID:17021016]."},"prefetch_data":{"uniprot":{"accession":"Q16760","full_name":"Diacylglycerol kinase delta","aliases":["130 kDa diacylglycerol kinase","Diglyceride kinase delta","DGK-delta"],"length_aa":1214,"mass_kda":134.5,"function":"Diacylglycerol kinase that converts diacylglycerol/DAG into phosphatidic acid/phosphatidate/PA and regulates the respective levels of these two bioactive lipids (PubMed:12200442, PubMed:23949095). Thereby, acts as a central switch between the signaling pathways activated by these second messengers with different cellular targets and opposite effects in numerous biological processes (Probable). By controlling the levels of diacylglycerol, regulates for instance the PKC and EGF receptor signaling pathways and plays a crucial role during development (By similarity). May also regulate clathrin-dependent endocytosis (PubMed:17880279)","subcellular_location":"Cell membrane; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q16760/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DGKD","classification":"Not Classified","n_dependent_lines":30,"n_total_lines":1208,"dependency_fraction":0.024834437086092714},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DGKD","total_profiled":1310},"omim":[{"mim_id":"609995","title":"MYOPIA 12, AUTOSOMAL DOMINANT; MYP12","url":"https://www.omim.org/entry/609995"},{"mim_id":"604071","title":"DIACYLGLYCEROL KINASE, ETA, 130-KD; DGKH","url":"https://www.omim.org/entry/604071"},{"mim_id":"601826","title":"DIACYLGLYCEROL KINASE, DELTA, 130-KD; DGKD","url":"https://www.omim.org/entry/601826"},{"mim_id":"300837","title":"DIACYLGLYCEROL KINASE, KAPPA, 142-KD; DGKK","url":"https://www.omim.org/entry/300837"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":29.7},{"tissue":"skeletal muscle","ntpm":26.7}],"url":"https://www.proteinatlas.org/search/DGKD"},"hgnc":{"alias_symbol":["KIAA0145","DGKdelta"],"prev_symbol":[]},"alphafold":{"accession":"Q16760","domains":[{"cath_id":"2.30.29.30","chopping":"46-156","consensus_level":"high","plddt":78.5996,"start":46,"end":156},{"cath_id":"2.60.200.40","chopping":"760-937","consensus_level":"medium","plddt":83.2815,"start":760,"end":937},{"cath_id":"1.20.120,1.20.1440","chopping":"974-1095","consensus_level":"high","plddt":81.0267,"start":974,"end":1095},{"cath_id":"1.10.150.50","chopping":"1143-1207","consensus_level":"high","plddt":90.3698,"start":1143,"end":1207},{"cath_id":"1.10.246","chopping":"477-524_534-557","consensus_level":"medium","plddt":74.865,"start":477,"end":557}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16760","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q16760-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q16760-F1-predicted_aligned_error_v6.png","plddt_mean":71.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DGKD","jax_strain_url":"https://www.jax.org/strain/search?query=DGKD"},"sequence":{"accession":"Q16760","fasta_url":"https://rest.uniprot.org/uniprotkb/Q16760.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q16760/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16760"}},"corpus_meta":[{"pmid":"18267070","id":"PMC_18267070","title":"Downregulation of diacylglycerol kinase delta contributes to hyperglycemia-induced insulin resistance.","date":"2008","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/18267070","citation_count":195,"is_preprint":false},{"pmid":"8626538","id":"PMC_8626538","title":"Molecular cloning of a novel diacylglycerol kinase isozyme with a pleckstrin homology domain and a C-terminal tail similar to those of the EPH family of protein-tyrosine kinases.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8626538","citation_count":158,"is_preprint":false},{"pmid":"24068962","id":"PMC_24068962","title":"Meta-analysis of genome-wide association studies identifies six new Loci for serum calcium concentrations.","date":"2013","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24068962","citation_count":156,"is_preprint":false},{"pmid":"16210324","id":"PMC_16210324","title":"Identification and characterization of a novel human type II diacylglycerol kinase, DGK kappa.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16210324","citation_count":107,"is_preprint":false},{"pmid":"31729369","id":"PMC_31729369","title":"Genetic variants of calcium and vitamin D metabolism in kidney stone disease.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31729369","citation_count":104,"is_preprint":false},{"pmid":"8702685","id":"PMC_8702685","title":"Cloning and characterization of a glucocorticoid-induced diacylglycerol kinase.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8702685","citation_count":91,"is_preprint":false},{"pmid":"12200442","id":"PMC_12200442","title":"Alternative splicing of the human diacylglycerol kinase delta gene generates two isoforms differing in their expression patterns and in regulatory functions.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12200442","citation_count":90,"is_preprint":false},{"pmid":"17021016","id":"PMC_17021016","title":"Diacylglycerol kinase delta regulates protein kinase C and epidermal growth factor receptor signaling.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17021016","citation_count":80,"is_preprint":false},{"pmid":"31848144","id":"PMC_31848144","title":"Germline genetic patterns underlying familial rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome highlight T cell-initiated autoimmunity.","date":"2019","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/31848144","citation_count":68,"is_preprint":false},{"pmid":"17675299","id":"PMC_17675299","title":"Glucose regulates diacylglycerol intracellular levels and protein kinase C activity by modulating diacylglycerol kinase subcellular localization.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17675299","citation_count":67,"is_preprint":false},{"pmid":"11809841","id":"PMC_11809841","title":"Diacylglycerol kinase delta suppresses ER-to-Golgi traffic via its SAM and PH domains.","date":"2002","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/11809841","citation_count":66,"is_preprint":false},{"pmid":"28918129","id":"PMC_28918129","title":"Where do substrates of diacylglycerol kinases come from? Diacylglycerol kinases utilize diacylglycerol species supplied from phosphatidylinositol turnover-independent pathways.","date":"2017","source":"Advances in biological regulation","url":"https://pubmed.ncbi.nlm.nih.gov/28918129","citation_count":66,"is_preprint":false},{"pmid":"32947951","id":"PMC_32947951","title":"New Era of Diacylglycerol Kinase, Phosphatidic Acid and Phosphatidic Acid-Binding Protein.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32947951","citation_count":63,"is_preprint":false},{"pmid":"12084710","id":"PMC_12084710","title":"Phorbol ester-regulated oligomerization of diacylglycerol kinase delta linked to its phosphorylation and translocation.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12084710","citation_count":60,"is_preprint":false},{"pmid":"23209562","id":"PMC_23209562","title":"Wiki-pi: a web-server of annotated human protein-protein interactions to aid in discovery of protein function.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23209562","citation_count":57,"is_preprint":false},{"pmid":"25112873","id":"PMC_25112873","title":"Diacylglycerol kinase δ phosphorylates phosphatidylcholine-specific phospholipase C-dependent, palmitic acid-containing diacylglycerol species in response to high glucose levels.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25112873","citation_count":52,"is_preprint":false},{"pmid":"28707095","id":"PMC_28707095","title":"Chronic administration of myristic acid improves hyperglycaemia in the Nagoya-Shibata-Yasuda mouse model of congenital type 2 diabetes.","date":"2017","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/28707095","citation_count":52,"is_preprint":false},{"pmid":"11309392","id":"PMC_11309392","title":"Nuclear diacylglycerol kinase-theta is activated in response to alpha-thrombin.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11309392","citation_count":51,"is_preprint":false},{"pmid":"22761715","id":"PMC_22761715","title":"Identification of kinases regulating prostate cancer cell growth using an RNAi phenotypic screen.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22761715","citation_count":44,"is_preprint":false},{"pmid":"17357084","id":"PMC_17357084","title":"Disruption of diacylglycerol kinase delta (DGKD) associated with seizures in humans and mice.","date":"2007","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17357084","citation_count":41,"is_preprint":false},{"pmid":"26530149","id":"PMC_26530149","title":"Diacylglycerol kinase-δ regulates AMPK signaling, lipid metabolism, and skeletal muscle energetics.","date":"2015","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/26530149","citation_count":30,"is_preprint":false},{"pmid":"17880279","id":"PMC_17880279","title":"Regulation of clathrin-dependent endocytosis by diacylglycerol kinase delta: importance of kinase activity and binding to AP2alpha.","date":"2008","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/17880279","citation_count":29,"is_preprint":false},{"pmid":"25362140","id":"PMC_25362140","title":"Expression and localization of type II diacylglycerol kinase isozymes δ and η in the developing mouse brain.","date":"2014","source":"The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society","url":"https://pubmed.ncbi.nlm.nih.gov/25362140","citation_count":28,"is_preprint":false},{"pmid":"27206979","id":"PMC_27206979","title":"Myristic Acid Enhances Diacylglycerol Kinase δ-Dependent Glucose Uptake in Myotubes.","date":"2016","source":"Lipids","url":"https://pubmed.ncbi.nlm.nih.gov/27206979","citation_count":26,"is_preprint":false},{"pmid":"32134507","id":"PMC_32134507","title":"1-Stearoyl-2-docosahexaenoyl-phosphatidic acid interacts with and activates Praja-1, the E3 ubiquitin ligase acting on the serotonin transporter in the brain.","date":"2020","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/32134507","citation_count":26,"is_preprint":false},{"pmid":"20857926","id":"PMC_20857926","title":"Zinc binding drives sheet formation by the SAM domain of diacylglycerol kinase δ.","date":"2010","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20857926","citation_count":25,"is_preprint":false},{"pmid":"31980461","id":"PMC_31980461","title":"Diacylglycerol kinase δ and sphingomyelin synthase-related protein functionally interact via their sterile α motif domains.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31980461","citation_count":24,"is_preprint":false},{"pmid":"27423518","id":"PMC_27423518","title":"Behavioral and pharmacological phenotypes of brain-specific diacylglycerol kinase δ-knockout mice.","date":"2016","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/27423518","citation_count":23,"is_preprint":false},{"pmid":"35121028","id":"PMC_35121028","title":"DNA methylation differences between male and female gonads of the oyster reveal the role of epigenetics in sex determination.","date":"2022","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/35121028","citation_count":23,"is_preprint":false},{"pmid":"33621517","id":"PMC_33621517","title":"Sphingomyelin synthase-related protein generates diacylglycerol via the hydrolysis of glycerophospholipids in the absence of ceramide.","date":"2021","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33621517","citation_count":23,"is_preprint":false},{"pmid":"28955976","id":"PMC_28955976","title":"Diacylglycerol kinase ζ generates dipalmitoyl-phosphatidic acid species during neuroblastoma cell differentiation.","date":"2016","source":"Biochemistry and biophysics reports","url":"https://pubmed.ncbi.nlm.nih.gov/28955976","citation_count":23,"is_preprint":false},{"pmid":"21477072","id":"PMC_21477072","title":"Diacylglycerol kinases are essential for hepatocyte growth factor-dependent proliferation and motility of Kaposi's sarcoma cells.","date":"2011","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/21477072","citation_count":22,"is_preprint":false},{"pmid":"33464721","id":"PMC_33464721","title":"Increasing skeletal muscle carnitine content in older individuals increases whole-body fat oxidation during moderate-intensity exercise.","date":"2021","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/33464721","citation_count":22,"is_preprint":false},{"pmid":"23184957","id":"PMC_23184957","title":"Diacylglycerol kinase δ modulates Akt phosphorylation through pleckstrin homology domain leucine-rich repeat protein phosphatase 2 (PHLPP2).","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23184957","citation_count":21,"is_preprint":false},{"pmid":"31010675","id":"PMC_31010675","title":"Creatine kinase muscle type specifically interacts with saturated fatty acid- and/or monounsaturated fatty acid-containing phosphatidic acids.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31010675","citation_count":21,"is_preprint":false},{"pmid":"20064931","id":"PMC_20064931","title":"Diacylglycerol kinase delta and protein kinase C(alpha) modulate epidermal growth factor receptor abundance and degradation through ubiquitin-specific protease 8.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20064931","citation_count":21,"is_preprint":false},{"pmid":"31891772","id":"PMC_31891772","title":"Diacylglycerol kinase δ destabilizes serotonin transporter protein through the ubiquitin-proteasome system.","date":"2019","source":"Biochimica et biophysica acta. Molecular and cell biology of lipids","url":"https://pubmed.ncbi.nlm.nih.gov/31891772","citation_count":20,"is_preprint":false},{"pmid":"25847921","id":"PMC_25847921","title":"mRNA expression of diacylglycerol kinase isoforms in insulin-sensitive tissues: effects of obesity and insulin resistance.","date":"2015","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/25847921","citation_count":19,"is_preprint":false},{"pmid":"24090246","id":"PMC_24090246","title":"Diacylglycerol kinase delta promotes lipogenesis.","date":"2013","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24090246","citation_count":19,"is_preprint":false},{"pmid":"24852321","id":"PMC_24852321","title":"Regulation of diacylglycerol kinase δ2 expression in C2C12 skeletal muscle cells by free fatty acids.","date":"2014","source":"Lipids","url":"https://pubmed.ncbi.nlm.nih.gov/24852321","citation_count":18,"is_preprint":false},{"pmid":"28120887","id":"PMC_28120887","title":"ER residency of the ceramide phosphoethanolamine synthase SMSr relies on homotypic oligomerization mediated by its SAM domain.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28120887","citation_count":18,"is_preprint":false},{"pmid":"22974639","id":"PMC_22974639","title":"Diacylglycerol kinase δ1 transiently translocates to the plasma membrane in response to high glucose.","date":"2012","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/22974639","citation_count":18,"is_preprint":false},{"pmid":"37469802","id":"PMC_37469802","title":"Optical Genome Mapping Identifies Novel Recurrent Structural Alterations in Childhood ETV6::RUNX1+ and High Hyperdiploid Acute Lymphoblastic Leukemia.","date":"2023","source":"HemaSphere","url":"https://pubmed.ncbi.nlm.nih.gov/37469802","citation_count":17,"is_preprint":false},{"pmid":"28706295","id":"PMC_28706295","title":"DGKδ triggers endoplasmic reticulum release of IFT88-containing vesicles destined for the assembly of primary cilia.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28706295","citation_count":15,"is_preprint":false},{"pmid":"19416640","id":"PMC_19416640","title":"Diacylglycerol kinase delta associates with receptor for activated C kinase 1, RACK1.","date":"2009","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/19416640","citation_count":15,"is_preprint":false},{"pmid":"23703849","id":"PMC_23703849","title":"Knockdown of diacylglycerol kinase delta inhibits adipocyte differentiation and alters lipid synthesis.","date":"2013","source":"Obesity (Silver Spring, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/23703849","citation_count":13,"is_preprint":false},{"pmid":"37932834","id":"PMC_37932834","title":"Inflammation and altered metabolism impede efficacy of functional electrical stimulation in critically ill patients.","date":"2023","source":"Critical care (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/37932834","citation_count":13,"is_preprint":false},{"pmid":"25886283","id":"PMC_25886283","title":"Genome-wide association study of serum minerals levels in children of different ethnic background.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25886283","citation_count":12,"is_preprint":false},{"pmid":"23940809","id":"PMC_23940809","title":"Clonal expansion analysis of transposon insertions by high-throughput sequencing identifies candidate cancer genes in a PiggyBac mutagenesis screen.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23940809","citation_count":12,"is_preprint":false},{"pmid":"30980919","id":"PMC_30980919","title":"Myristic acid specifically stabilizes diacylglycerol kinase δ protein in C2C12 skeletal muscle cells.","date":"2019","source":"Biochimica et biophysica acta. Molecular and cell biology of lipids","url":"https://pubmed.ncbi.nlm.nih.gov/30980919","citation_count":11,"is_preprint":false},{"pmid":"40372791","id":"PMC_40372791","title":"Genetic variants predisposing to an increased risk of kidney stone disease.","date":"2025","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/40372791","citation_count":10,"is_preprint":false},{"pmid":"29486157","id":"PMC_29486157","title":"Abnormalities of the serotonergic system in diacylglycerol kinase δ-deficient mouse brain.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29486157","citation_count":10,"is_preprint":false},{"pmid":"29859210","id":"PMC_29859210","title":"Diacylglycerol kinase δ controls down-regulation of cyclin D1 for C2C12 myogenic differentiation.","date":"2018","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/29859210","citation_count":10,"is_preprint":false},{"pmid":"28742439","id":"PMC_28742439","title":"DaMab-2: Anti-Human DGKα Monoclonal Antibody for Immunocytochemistry.","date":"2017","source":"Monoclonal antibodies in immunodiagnosis and immunotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/28742439","citation_count":10,"is_preprint":false},{"pmid":"38843995","id":"PMC_38843995","title":"Diacylglycerol kinase delta overexpression improves glucose clearance and protects against the development of obesity.","date":"2024","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/38843995","citation_count":9,"is_preprint":false},{"pmid":"35406411","id":"PMC_35406411","title":"Targeting circDGKD Intercepts TKI's Effects on Up-Regulation of Estrogen Receptor β and Vasculogenic Mimicry in Renal Cell Carcinoma.","date":"2022","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/35406411","citation_count":9,"is_preprint":false},{"pmid":"25972035","id":"PMC_25972035","title":"Association of common variants in the calcium-sensing receptor gene with serum calcium levels in East Asians.","date":"2015","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25972035","citation_count":9,"is_preprint":false},{"pmid":"35856166","id":"PMC_35856166","title":"Myristic acid selectively augments β-tubulin levels in C2C12 myotubes via diacylglycerol kinase δ.","date":"2022","source":"FEBS open bio","url":"https://pubmed.ncbi.nlm.nih.gov/35856166","citation_count":8,"is_preprint":false},{"pmid":"33774855","id":"PMC_33774855","title":"Diacylglycerol kinase δ functions as a proliferation suppressor in pancreatic β-cells.","date":"2021","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/33774855","citation_count":8,"is_preprint":false},{"pmid":"39368888","id":"PMC_39368888","title":"Upstream and downstream pathways of diacylglycerol kinase : Novel phosphatidylinositol turnover-independent signal transduction pathways.","date":"2024","source":"Advances in biological regulation","url":"https://pubmed.ncbi.nlm.nih.gov/39368888","citation_count":7,"is_preprint":false},{"pmid":"10224565","id":"PMC_10224565","title":"Construction and sequence analysis of subtraction complementary DNA libraries from human preimplantation embryos.","date":"1999","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10224565","citation_count":7,"is_preprint":false},{"pmid":"37942667","id":"PMC_37942667","title":"Comparative analysis of PDZ-binding motifs in the diacylglycerol kinase family.","date":"2023","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/37942667","citation_count":7,"is_preprint":false},{"pmid":"38916734","id":"PMC_38916734","title":"Adiponectin mRNA Conjugated with Lipid Nanoparticles Specifically Targets the Pathogenesis of Type 2 Diabetes.","date":"2024","source":"Aging and disease","url":"https://pubmed.ncbi.nlm.nih.gov/38916734","citation_count":7,"is_preprint":false},{"pmid":"31837836","id":"PMC_31837836","title":"d-Glycerate kinase deficiency in a neuropediatric patient.","date":"2019","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/31837836","citation_count":5,"is_preprint":false},{"pmid":"39992810","id":"PMC_39992810","title":"Human PHOSPHO1 exhibits phosphatidylcholine- and phosphatidylethanolamine-phospholipase C activities and interacts with diacylglycerol kinase δ.","date":"2025","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/39992810","citation_count":5,"is_preprint":false},{"pmid":"30715374","id":"PMC_30715374","title":"Screening of subtype-specific activators and inhibitors for diacylglycerol kinase.","date":"2019","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30715374","citation_count":5,"is_preprint":false},{"pmid":"37509516","id":"PMC_37509516","title":"Role of Diacylglycerol Kinases in Acute Myeloid Leukemia.","date":"2023","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/37509516","citation_count":5,"is_preprint":false},{"pmid":"35472624","id":"PMC_35472624","title":"Hepatic glycerolipid metabolism is critical to the egg laying rate of Guangxi Ma chickens.","date":"2022","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/35472624","citation_count":5,"is_preprint":false},{"pmid":"33997319","id":"PMC_33997319","title":"Diacylglycerol kinase η colocalizes and interacts with apoptosis signal-regulating kinase 3 in response to osmotic shock.","date":"2021","source":"Biochemistry and biophysics reports","url":"https://pubmed.ncbi.nlm.nih.gov/33997319","citation_count":3,"is_preprint":false},{"pmid":"39603461","id":"PMC_39603461","title":"Ubiquitin-specific peptidase 11 selectively interacts with and deubiquitination-dependently stabilizes diacylglycerol kinase δ to maintain cellular glucose uptake.","date":"2024","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/39603461","citation_count":2,"is_preprint":false},{"pmid":"39781426","id":"PMC_39781426","title":"Diacylglycerol kinase δ is required for skeletal muscle development and regeneration.","date":"2024","source":"FASEB bioAdvances","url":"https://pubmed.ncbi.nlm.nih.gov/39781426","citation_count":2,"is_preprint":false},{"pmid":"28377914","id":"PMC_28377914","title":"A Case of 22q11 Deletion Syndrome (22q11DS) with a Panayiotopoulos Epileptic Pattern: Are Additional Copy-Number Variations a Possible Second Hit in Modulating the 22q11DS Phenotype?","date":"2017","source":"Frontiers in pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/28377914","citation_count":2,"is_preprint":false},{"pmid":"22406787","id":"PMC_22406787","title":"Analysis of the genotype of diacylglycerol kinase delta single-nucleotide polymorphisms in Parkinson disease in the Han Chinese population.","date":"2012","source":"Neurology India","url":"https://pubmed.ncbi.nlm.nih.gov/22406787","citation_count":1,"is_preprint":false},{"pmid":"41080753","id":"PMC_41080753","title":"Saturated fatty acid- and/or monounsaturated fatty acid-containing-phosphatidic acids selectively interact with and activate phosphoglycerate mutase 1.","date":"2025","source":"Biochemistry and biophysics reports","url":"https://pubmed.ncbi.nlm.nih.gov/41080753","citation_count":1,"is_preprint":false},{"pmid":"39637364","id":"PMC_39637364","title":"IDENTIFICATION AND VERIFICATION OF FEATURE BIOMARKERS ASSOCIATED WITH CHOLINE METABOLISM IN SEPSIS-INDUCED CARDIOMYOPATHY.","date":"2024","source":"Shock (Augusta, Ga.)","url":"https://pubmed.ncbi.nlm.nih.gov/39637364","citation_count":1,"is_preprint":false},{"pmid":"37121690","id":"PMC_37121690","title":"Development of Therapeutic Agents with a Novel Mechanism of Action Targeting Pancreatic β-Cells for Diabetes.","date":"2023","source":"Biological & pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/37121690","citation_count":1,"is_preprint":false},{"pmid":"41431653","id":"PMC_41431653","title":"Sex-specific circRNA-miRNA-mRNA networks in peripheral blood mononuclear cells of patients with idiopathic pulmonary arterial hypertension: a pilot study.","date":"2025","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/41431653","citation_count":1,"is_preprint":false},{"pmid":"40921406","id":"PMC_40921406","title":"Diacylglycerol kinase gene Dgkh deficiency disrupts testicular lipid balance in male mice without affecting fertility.","date":"2025","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/40921406","citation_count":0,"is_preprint":false},{"pmid":"32944659","id":"PMC_32944659","title":"Epitope mapping of an anti-diacylglycerol kinase delta monoclonal antibody DdMab-1.","date":"2020","source":"Biochemistry and biophysics reports","url":"https://pubmed.ncbi.nlm.nih.gov/32944659","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.06.07.24308490","title":"Genetic variants predisposing to increased risk of kidney stone disease","date":"2024-06-11","source":"bioRxiv","url":"https://doi.org/10.1101/2024.06.07.24308490","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":42762,"output_tokens":7953,"usd":0.12379},"stage2":{"model":"claude-opus-4-6","input_tokens":12085,"output_tokens":4189,"usd":0.247725},"total_usd":0.371515,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"DGKδ was cloned and identified as a diacylglycerol kinase with a pleckstrin homology (PH) domain, two cysteine-rich zinc finger-like (C1) structures, a C-terminal SAM-like tail similar to EPH receptor tyrosine kinases, and a long Glu/Ser-rich insertion. Increased DGK activity was detected in the particulate fraction of COS-7 cells expressing transfected DGKδ cDNA, independent of phosphatidylserine activation.\",\n      \"method\": \"cDNA cloning, transfection in COS-7 cells, DGK activity assay, Northern blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original biochemical characterization with direct enzyme activity assay in transfected cells\",\n      \"pmids\": [\"8626538\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Alternative splicing of human DGKD generates two isoforms (DGKδ1, 130 kDa; DGKδ2, 135 kDa) with distinct expression patterns and regulatory functions. DGKδ1 translocates from cytoplasm to plasma membrane via its PH domain in response to phorbol ester, whereas DGKδ2 remains cytoplasmic due to its N-terminal extension blocking translocation. The two isoforms form homo- and hetero-oligomers detected by co-immunoprecipitation.\",\n      \"method\": \"RT-PCR, phorbol ester stimulation, co-immunoprecipitation, subcellular fractionation, live cell imaging\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (co-IP, translocation assay, expression analysis) in single rigorous study\",\n      \"pmids\": [\"12200442\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"DGKδ suppresses anterograde ER-to-Golgi transport via its SAM domain (acting as ER-targeting motif) and PH domain, without requiring kinase activity. DGKδ expression caused redistribution of Golgi and VTC marker proteins to the ER, delayed VSV-G transport, and abrogated COPII-coated structure formation (Sec13p-labeled) without affecting COPI retrograde structures.\",\n      \"method\": \"NIH3T3 cell expression, live imaging of VSV-G trafficking, BFA washout assay, kinase-dead mutant analysis, COPII/COPI marker immunostaining\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal experiments including kinase-dead mutants and domain dissection with defined trafficking phenotype\",\n      \"pmids\": [\"11809841\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"DGKδ forms homo-oligomeric structures via its SAM domain in intact cells; phorbol ester stimulation induces PKC-dependent phosphorylation of DGKδ, dissociation of oligomers, and translocation from cytoplasmic vesicles to the plasma membrane. SAM-domain mutants unable to self-associate constitutively localize to the plasma membrane.\",\n      \"method\": \"Yeast two-hybrid, bacterially expressed SAM domain gel filtration, co-immunoprecipitation, phorbol ester stimulation, PKC inhibitor (staurosporine) treatment, subcellular fractionation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (yeast 2-hybrid, gel filtration, co-IP, mutant analysis) with functional translocation readout\",\n      \"pmids\": [\"12084710\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"DGKδ deficiency in mice causes DAG accumulation, increased PKC-mediated threonine phosphorylation of EGFR, reduced EGFR protein expression and activity, and enhanced phosphorylation of other PKC substrates. DGKδ knockout pups phenocopy EGFR knockout mice (open eyelids, neonatal lethality), establishing DGKδ as a regulator of PKC-EGFR signaling.\",\n      \"method\": \"Gene knockout in mice, Western blot for phospho-EGFR and PKC substrates, DAG measurement, phenotypic analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout with defined molecular and phenotypic readouts, replicated in multiple tissues\",\n      \"pmids\": [\"17021016\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Short-term high glucose exposure transiently redistributes DGKδ from cytoplasm to plasma membrane in L6 myotubes, activating DGK activity and reducing intracellular DAG and PKCα activity, thereby transactivating insulin receptor signaling and GLUT4 translocation. Antisense silencing of DGKδ (but not DGKα) prevented these effects, establishing DGKδ as the mediator of glucose-induced acute DGK activation in skeletal muscle.\",\n      \"method\": \"L6 myotube antisense silencing, DGK inhibitor (R59949), subcellular fractionation, PKCα activity assay, insulin receptor phosphorylation, GLUT4 translocation imaging\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — isoform-specific silencing with multiple orthogonal readouts establishing pathway position\",\n      \"pmids\": [\"17675299\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Reduced DGKδ expression and DGK activity were found in skeletal muscle of type 2 diabetic patients. DGKδ haploinsufficiency in mice increased DAG content, reduced peripheral insulin sensitivity, impaired insulin signaling and glucose transport, and caused age-dependent obesity and metabolic inflexibility, establishing DGKδ as a contributor to hyperglycemia-induced peripheral insulin resistance.\",\n      \"method\": \"Human skeletal muscle biopsies (T2D patients vs controls), DGKδ haploinsufficient mouse model, DAG measurement, insulin tolerance test, glucose transport assay, metabolic cage studies\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — human tissue data combined with genetic mouse model with multiple metabolic readouts; highly cited foundational study\",\n      \"pmids\": [\"18267070\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"DGKδ2 binds to AP2α (adaptor protein 2 alpha) via DXF-type motifs (F369DTFRIL and D746PF) in the catalytic domain, interacting with the AP2α ear platform subdomain. This interaction, together with DGK kinase activity, is required for clathrin-dependent endocytosis (transferrin internalization). Mutants lacking AP2α binding or kinase activity failed to rescue endocytosis impaired by DGKδ siRNA knockdown.\",\n      \"method\": \"Co-immunoprecipitation, domain mapping, transferrin/EGF uptake assay, siRNA knockdown, overexpression of wild-type and mutant DGKδ2\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — binding domain mapping with functional rescue assay requiring both binding and catalytic activity\",\n      \"pmids\": [\"17880279\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"DGKδ interacts with RACK1 (receptor for activated C kinase 1) via WD40 repeats 5–7 of RACK1. Co-immunoprecipitation confirmed selective interaction of RACK1 with DGKδ but not type I DGKs in mammalian cells. The interaction is regulated by phorbol ester and DGKδ recruits RACK1 to clathrin-coated vesicles.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation in COS-7 cells, phorbol ester treatment, colocalization imaging\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — yeast 2-hybrid confirmed by co-IP, functional consequence inferred from localization\",\n      \"pmids\": [\"19416640\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"DGKδ deficiency leads to enhanced ubiquitination of EGFR and reduced expression of deubiquitinase USP8, promoting EGFR degradation. This is mediated through excessive PKCα activity (due to DAG accumulation) inhibiting Akt, which normally stabilizes USP8. Depletion of PKCα or PHLPP2 rescued USP8 levels and normalized EGFR degradation in DGKδ-deficient cells.\",\n      \"method\": \"DGKδ knockout MEFs, siRNA knockdown of PKCα/PHLPP2, ubiquitination assay, Western blot for USP8/EGFR/Akt\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO plus rescue experiments with multiple epistasis steps demonstrating pathway\",\n      \"pmids\": [\"20064931\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The SAM domain of DGKδ1 binds zinc at multiple sites, driving formation of large sheets of helical polymers. Zinc-binding is required for cytoplasmic puncta formation and regulation of plasma membrane transport; a SAM domain mutant refractory to zinc binding showed diminished puncta, partially impaired plasma membrane transport regulation, and lost ability to inhibit COPII vesicle formation.\",\n      \"method\": \"Biochemical zinc-binding assay, gel filtration, electron microscopy of SAM polymer sheets, DGKδ SAM zinc-binding mutant, live cell imaging of puncta, COPII vesicle formation assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution of zinc-driven SAM oligomerization combined with mutagenesis and cellular functional assays\",\n      \"pmids\": [\"20857926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"DGKδ deficiency reduces Akt phosphorylation downstream of three receptor tyrosine kinases via a pathway involving excessive PKCα activity promoting Akt dephosphorylation through PHLPP2, with β-arrestin 1 acting as scaffold for PHLPP2 and Akt1. Depletion of PKCα or PHLPP2 (but not PHLPP1) rescued Akt phosphorylation in DGKδ-deficient cells. DGKδ deficiency also reduced cell proliferation and migration and enhanced apoptosis.\",\n      \"method\": \"DGKδ knockout cells, siRNA knockdown of PKCα/PHLPP1/PHLPP2/β-arrestin 1, phospho-Akt Western blot, cell proliferation and migration assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple epistasis knockdown experiments defining precise pathway order with multiple orthogonal readouts\",\n      \"pmids\": [\"23184957\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"DGKδ1, but not DGKδ2 or DGKη1/2, translocates from cytoplasm to plasma membrane within 5 min in response to high glucose. This translocation is dependent on PI3K signaling and requires both PH and C1 domains; the SAM domain negatively regulates this translocation.\",\n      \"method\": \"HEK293 and C2C12 cell imaging, PI3K inhibitor (LY294002, GDC-0941) treatment, domain deletion mutants, high glucose stimulation\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — domain dissection with pharmacological inhibition and multiple isoform controls establishing isoform-specific mechanism\",\n      \"pmids\": [\"22974639\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"DGKδ preferentially phosphorylates palmitic acid (16:0)-containing diacylglycerol species (30:0-, 32:0-, 34:0-PA and related monounsaturated species) in high glucose-stimulated C2C12 myoblasts. These DG substrates are supplied via the phosphatidylcholine-specific phospholipase C (PC-PLC) pathway, not from phosphatidylinositol turnover-derived 20:4-DG. PC-PLC was co-immunoprecipitated with DGKδ2.\",\n      \"method\": \"LC-MS analysis of PA species, DGKδ-specific siRNA knockdown, DGKδ2 overexpression, PC-PLC inhibitor D609, co-immunoprecipitation of PC-PLC with DGKδ2\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — LC-MS/MS substrate identification combined with siRNA, overexpression, inhibitor, and co-IP approaches\",\n      \"pmids\": [\"25112873\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DGKδ deficiency impairs AMPK activation and signaling in skeletal muscle, concomitant with impaired lipid oxidation and elevated incorporation of free fatty acids into triglycerides. DGKδ(+/-) mice also showed reduced voluntary running and impaired force production and relaxation dynamics during repeated contractions.\",\n      \"method\": \"DGKδ haploinsufficient mice, AMPK phosphorylation assay, lipid oxidation measurement, fatty acid incorporation assay, voluntary wheel running, ex vivo muscle contraction\",\n      \"journal\": \"American journal of physiology. Endocrinology and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic model with multiple biochemical and physiological readouts\",\n      \"pmids\": [\"26530149\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Brain-specific DGKδ knockout mice exhibit OCD-like behaviors (compulsive checking in novel object recognition, increased marble burying) alleviated by the serotonin reuptake inhibitor fluoxetine. DGKδ deficiency increases axon/neurite outgrowth in primary cortical neurons and DGKδ-knockdown neuroblastoma cells, while DGKδ overexpression decreases neurite number.\",\n      \"method\": \"Brain-specific conditional DGKδ KO mice, behavioral tests (novel object recognition, marble burying), fluoxetine pharmacological rescue, primary neuron and Neuro-2a cell morphology analysis\",\n      \"journal\": \"Brain research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with behavioral phenotype and pharmacological rescue, plus cellular mechanistic data\",\n      \"pmids\": [\"27423518\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"DGKδ is a residential lipid kinase in the ER that triggers release of IFT88-containing COPII-coated vesicles from ER exit sites (ERES) for delivery to primary cilia. IFT88 physically interacts with DGKδ. DGKδ is required for Sonic hedgehog (Shh) signal transduction both in vitro and in vivo.\",\n      \"method\": \"Co-immunoprecipitation of IFT88 with DGKδ, RNAi silencing and gene KO, COPII vesicle formation assay, Shh signaling reporter assay, primary cilia formation imaging\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — physical interaction combined with KO/KD functional assays establishing pathway role in ciliogenesis and Shh signaling\",\n      \"pmids\": [\"28706295\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"DGKδ deficiency in the brain increases SERT protein levels in the cerebral cortex, and DGKδ physically interacts and co-localizes with SERT. DGKδ-KO also decreases tryptophan hydroxylase-2 expression, increases monoamine oxidase-A expression, and reduces serotonin levels in the cerebral cortex, indicating comprehensive serotonergic hypofunction.\",\n      \"method\": \"Brain-specific DGKδ KO mice, Western blot for SERT/TPH2/MAO-A, serotonin ELISA, co-immunoprecipitation/colocalization of DGKδ and SERT\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO combined with physical interaction data and multiple serotonergic pathway readouts\",\n      \"pmids\": [\"29486157\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"DGKδ controls cyclin D1 downregulation during C2C12 myogenic differentiation by attenuating PKC signaling. DGKδ knockdown increased cyclin D1 expression and phospho-PKC (conventional and novel isoforms) while decreasing myogenin expression and myosin heavy chain-positive cell number.\",\n      \"method\": \"C2C12 myogenic differentiation model, DGKδ-specific siRNA, Western blot for cyclin D1/myogenin/MHC/phospho-PKC, MHC immunofluorescence\",\n      \"journal\": \"Biochimie\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KD with multiple molecular readouts but single lab, no rescue experiment\",\n      \"pmids\": [\"29859210\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"DGKδ interacts with MAGE-D1 adaptor protein and Praja-1 E3 ubiquitin-protein ligase. DGKδ catalytic subdomain-a and coiled-coil region interact with the C-terminal cytoplasmic region of SERT. DGKδ promotes SERT ubiquitination through Praja-1 and induces SERT degradation via the ubiquitin-proteasome system in a DGKδ catalytic activity-dependent manner.\",\n      \"method\": \"Co-immunoprecipitation, domain mapping, overexpression/knockdown in cells, proteasome inhibitor MG-132, ubiquitination assay\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular and cell biology of lipids\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — physical interaction with domain mapping, functional ubiquitination assay, pharmacological validation, and catalytic activity-dependence demonstrated\",\n      \"pmids\": [\"31891772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"DGKD knockdown in vitro impairs calcium-sensing receptor (CaSR) signal transduction, an effect rectified by the calcimimetic cinacalcet, placing DGKδ as a component of CaSR signaling and linking it to urinary calcium excretion.\",\n      \"method\": \"siRNA knockdown of DGKD in cells, CaSR signaling assay, cinacalcet rescue, GWAS and validation cohort correlation with urinary calcium\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro KD with pharmacological rescue establishing DGKδ in CaSR pathway, supported by genetic association\",\n      \"pmids\": [\"31729369\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DGKδ selectively phosphorylates 18:0/22:6-DG to generate 18:0/22:6-phosphatidic acid (PA) in the brain. 18:0/22:6-PA selectively binds to and enhances the E3 ubiquitin ligase activity of Praja-1, mechanistically linking DGKδ-generated PA species to SERT degradation.\",\n      \"method\": \"DGKδ-KO mouse brain lipidomic profiling (LC-MS), lipid-protein binding assay, Praja-1 activity assay with specific PA species\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vivo substrate identification by KO lipidomics combined with in vitro enzymatic activity assay demonstrating PA species selectivity\",\n      \"pmids\": [\"32134507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DGKδ interacts with sphingomyelin synthase-related protein (SMSr) through their respective SAM domains. SMSr overexpression enhances production of 16:0- or 16:1-containing PA species in DGKδ-overexpressing cells, and SMSr enhances DGKδ activity via their SAMDs in vitro, establishing SMSr as an upstream DG-providing enzyme for DGKδ.\",\n      \"method\": \"Co-immunoprecipitation of full-length and SAM domain deletion mutants, LC-MS/MS of PA species, in vitro DGKδ activity assay with SMSr\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic activation assay combined with domain-mapping co-IP and quantitative lipidomics\",\n      \"pmids\": [\"31980461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"β-cell-specific DGKδ knockout mice showed lower blood glucose, higher insulin, better glucose tolerance, increased Ki-67-positive islet cells, and elevated cyclin B1 expression, demonstrating DGKδ functions as a proliferation suppressor in pancreatic β-cells. DGKδ knockdown in MIN6 cells also increased BrdU incorporation and cyclin B1 expression.\",\n      \"method\": \"β-cell-specific DGKδ KO mice, glucose tolerance tests, Ki-67/BrdU proliferation assays, cyclin B1 Western blot, streptozotocin model\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific KO with multiple proliferation and metabolic readouts validated in cell line\",\n      \"pmids\": [\"33774855\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"USP11 (ubiquitin-specific peptidase 11) physically interacts with DGKδ via USP11 catalytic domain 1 region and DGKδ C1 domains/catalytic subdomain-a. USP11 deubiquitinates and stabilizes DGKδ protein; USP11 inhibition or knockdown increases DGKδ ubiquitination and decreases DGKδ protein levels, impairing cellular glucose uptake.\",\n      \"method\": \"DGKδ interactome analysis, co-immunoprecipitation, domain mapping, USP11 inhibitor (mitoxantrone), siRNA knockdown, ubiquitination assay, glucose uptake assay\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — interactome-based discovery confirmed by domain mapping, pharmacological and genetic KD, ubiquitination assay, and functional readout\",\n      \"pmids\": [\"39603461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Myf5-promoter-driven conditional DGKδ knockout mice showed reduced body weight, decreased skeletal muscle mass, and reduced myofiber thickness. Cardiotoxin-induced muscle injury revealed that DGKδ is strongly upregulated in myogenin-positive satellite cells, and DGKδ deficiency impaired myofiber formation, myogenic marker expression (embryonic myosin heavy chain, myogenin), and satellite cell-mediated muscle regeneration.\",\n      \"method\": \"Conditional Myf5-Cre DGKδ KO mice, cardiotoxin injury model, immunofluorescence for satellite cell markers, Western blot for myogenic differentiation markers, histological analysis\",\n      \"journal\": \"FASEB bioAdvances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with injury model establishing DGKδ role in satellite cell-mediated regeneration with molecular markers\",\n      \"pmids\": [\"39781426\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Reduced DGKδ expression and KSD-associated DGKD missense variants impair CaSR signal transduction in vitro, demonstrable with cellular assays, and this impairment is ameliorated by cinacalcet (positive CaSR allosteric modulator), further confirming DGKδ as a functional partner of CaSR signaling.\",\n      \"method\": \"siRNA knockdown and missense variant overexpression in cells, CaSR signaling assay, cinacalcet pharmacological rescue\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KD plus variant functional study with pharmacological rescue; extends prior work from PMID 31729369\",\n      \"pmids\": [\"40372791\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PHOSPHO1, a cytosolic protein, exhibits D609-sensitive PC-PLC and PE-PLC activities and its overexpression increases saturated/monounsaturated fatty acid-containing DG levels in HEK293 cells. PHOSPHO1 co-sediments and co-localizes with DGKδ, identifying it as a candidate cytosolic DG-generating enzyme upstream of DGKδ.\",\n      \"method\": \"In vitro enzyme activity assay of purified PHOSPHO1 with PC/PE substrates, D609 inhibitor, DG species quantification by LC-MS in overexpressing cells, co-sedimentation and colocalization with DGKδ\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 for PHOSPHO1 enzymatic activity; Tier 3 for DGKδ interaction (co-sedimentation only); overall Medium\",\n      \"pmids\": [\"39992810\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"DGKδ promotes lipogenesis: DGKδ expression is markedly increased during 3T3-L1 adipocyte differentiation, DGKδ transfection increases triglyceride synthesis, and DGKδ knockout MEFs show reduced synthesis of neutral and polar lipids, particularly those with shorter acyl chains, and lower expression of acetyl-CoA carboxylase, fatty acid synthase, and activation of ATP citrate lyase.\",\n      \"method\": \"3T3-L1 differentiation assay, DGKδ transfection, DGKδ KO MEFs, glycerol incorporation assay, lipidomics, Western blot for lipogenic enzymes\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain- and loss-of-function with lipidomics and enzyme expression data in multiple cell systems\",\n      \"pmids\": [\"24090246\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Creatine kinase muscle type (CKM) specifically binds 16:0/16:0-PA and other saturated/monounsaturated fatty acid-containing PA species (but not PUFA-containing PAs, and not other phospholipids) with high affinity (Kd ~2.0 μM), identifying CKM as a selective downstream target of DGKδ-produced PA species in skeletal muscle.\",\n      \"method\": \"Protein pulldown from mouse skeletal muscle, lipid-protein binding assay with defined PA species, dissociation constant measurement\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — in vitro binding assay with lipid selectivity characterization, no functional readout of CKM activation by DGKδ-PA\",\n      \"pmids\": [\"31010675\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DGKδ is a lipid kinase that phosphorylates diacylglycerol (preferentially saturated/monounsaturated fatty acid-containing DG species supplied by the PC-PLC/SMSr/PHOSPHO1 pathway rather than PI-turnover-derived 18:0/20:4-DG) to generate phosphatidic acid, thereby terminating DAG-PKC signaling; it is regulated by SAM domain-mediated zinc-dependent oligomerization controlling its localization (cytoplasmic puncta vs. plasma membrane), interacts with AP2α to regulate clathrin-dependent endocytosis, with SERT/Praja-1 to promote ubiquitin-proteasome degradation of SERT via 18:0/22:6-PA, with IFT88 to trigger ER export of ciliary cargo, and with CaSR signaling components; its stability is maintained by USP11-mediated deubiquitination, and its deficiency impairs skeletal muscle insulin signaling, AMPK activation, myogenic differentiation, and regeneration, while its brain-specific loss causes serotonergic dysfunction and OCD-like behavior.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"DGKδ is a diacylglycerol kinase that phosphorylates saturated and monounsaturated fatty acid-containing diacylglycerol species—supplied by PC-PLC/SMSr/PHOSPHO1 pathways rather than PI-turnover—to generate phosphatidic acid, thereby terminating DAG-PKC signaling and producing bioactive PA species with distinct downstream effectors [PMID:25112873, PMID:31980461, PMID:32134507]. Its subcellular distribution is governed by SAM domain-mediated zinc-dependent oligomerization, which retains DGKδ in cytoplasmic puncta; PKC-dependent phosphorylation or PI3K-dependent signals dissociate oligomers and drive PH/C1 domain-dependent translocation to the plasma membrane, where it attenuates DAG-PKC signaling to sustain insulin receptor/Akt activity, regulate EGFR stability, support clathrin-dependent endocytosis via AP2α binding, and promote SERT ubiquitin-proteasomal degradation through Praja-1 activation by 18:0/22:6-PA [PMID:12084710, PMID:20857926, PMID:17021016, PMID:17880279, PMID:31891772]. As a residential ER lipid kinase, DGKδ also triggers COPII-dependent ER export of IFT88-containing vesicles required for ciliogenesis and Sonic hedgehog signaling [PMID:28706295]. Loss of DGKδ in mice causes tissue-specific phenotypes including peripheral insulin resistance with age-dependent obesity in skeletal muscle haploinsufficiency, impaired myogenic differentiation and satellite cell-mediated regeneration, β-cell hyperproliferation, serotonergic hypofunction with OCD-like behavior in brain-specific knockouts, and neonatal lethality phenocopying EGFR-null mice in full knockouts [PMID:18267070, PMID:39781426, PMID:33774855, PMID:27423518, PMID:17021016].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Establishing DGKδ as a new DAG kinase family member with a unique domain architecture (PH, C1, SAM) answered the question of whether additional DGK isoforms with distinct regulatory properties existed.\",\n      \"evidence\": \"cDNA cloning and DGK activity assay in transfected COS-7 cells\",\n      \"pmids\": [\"8626538\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Substrate specificity unknown\", \"Physiological function not established\", \"SAM domain function not determined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Discovery that alternative splicing generates two isoforms with distinct translocation behaviors, and that the SAM domain drives zinc-dependent homo-oligomerization controlling cytoplasm-to-membrane redistribution, established the core regulatory logic of DGKδ activation.\",\n      \"evidence\": \"Co-IP of isoform oligomers, phorbol ester-induced translocation imaging, yeast two-hybrid and gel filtration of SAM domain, domain deletion mutants in NIH3T3/COS-7 cells\",\n      \"pmids\": [\"12200442\", \"12084710\", \"11809841\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Zinc-binding stoichiometry and structural basis of SAM polymers not resolved\", \"Whether kinase activity is required for all trafficking functions unclear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Genetic ablation in mice revealed that DGKδ is essential for restraining DAG-PKC signaling in vivo, as knockout caused DAG accumulation, hyperactive PKC-mediated EGFR threonine phosphorylation, and neonatal lethality phenocopying EGFR-null mice.\",\n      \"evidence\": \"DGKδ knockout mice with DAG measurement, phospho-EGFR Western blot, phenotypic analysis\",\n      \"pmids\": [\"17021016\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific contributions to lethality not dissected\", \"Whether PA production or solely DAG clearance drives the phenotype not resolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Two studies established DGKδ as a metabolic regulator: reduced expression in human type 2 diabetic muscle linked it to insulin resistance, haploinsufficient mice confirmed DAG-dependent impairment of insulin signaling and glucose transport, and AP2α binding coupled DGKδ kinase activity to clathrin-dependent endocytosis.\",\n      \"evidence\": \"Human skeletal muscle biopsies, DGKδ haploinsufficient mice with metabolic phenotyping, AP2α co-IP with domain mapping and transferrin uptake rescue\",\n      \"pmids\": [\"18267070\", \"17880279\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism connecting DGKδ-PA to AP2α-dependent vesicle formation not defined\", \"Whether insulin resistance is solely PKC-mediated or involves PA effectors unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Biochemical reconstitution showed the SAM domain forms zinc-driven helical polymer sheets, and epistasis experiments in KO cells defined the DGKδ→DAG→PKCα→PHLPP2→Akt→USP8→EGFR degradation pathway, answering how DGKδ loss destabilizes EGFR.\",\n      \"evidence\": \"Electron microscopy of SAM polymers, zinc-binding mutant functional assays, DGKδ-KO MEFs with siRNA epistasis for PKCα/PHLPP2/USP8\",\n      \"pmids\": [\"20857926\", \"20064931\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether zinc-SAM polymers form in vivo not confirmed\", \"PHLPP2-Akt-USP8 axis not validated in intact organisms\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"The PKCα-PHLPP2-Akt axis downstream of DGKδ was generalized beyond EGFR to three receptor tyrosine kinases, with β-arrestin 1 identified as the scaffold, and glucose-induced DGKδ1 translocation was shown to require PI3K and PH/C1 domains.\",\n      \"evidence\": \"DGKδ-KO cells with siRNA knockdown of PKCα/PHLPP1/PHLPP2/β-arrestin 1, PI3K inhibitor treatment and domain deletion mutants in HEK293/C2C12\",\n      \"pmids\": [\"23184957\", \"22974639\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"PI3K-dependent translocation mechanism (lipid product sensed by PH domain?) not molecularly defined\", \"In vivo relevance of β-arrestin 1 scaffolding not tested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"LC-MS lipidomics resolved DGKδ substrate specificity: it preferentially phosphorylates 16:0-containing DAG species derived from the PC-PLC pathway, not PI-turnover-derived arachidonoyl-DAG, fundamentally redefining DGKδ as a DAG kinase operating in a non-canonical lipid metabolic branch.\",\n      \"evidence\": \"LC-MS PA species analysis after DGKδ siRNA/overexpression in C2C12 myoblasts, PC-PLC inhibitor D609, co-IP of PC-PLC with DGKδ2\",\n      \"pmids\": [\"25112873\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the PC-PLC enzyme upstream of DGKδ not genetically confirmed\", \"Whether substrate selectivity reflects DGKδ intrinsic preference or substrate availability unclear\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Brain-specific knockout revealed that DGKδ regulates serotonergic tone and neuronal morphology, with loss causing OCD-like behavior rescued by fluoxetine and enhanced neurite outgrowth, expanding DGKδ function from metabolism to neuropsychiatric circuits.\",\n      \"evidence\": \"Brain-specific conditional KO mice with behavioral tests and pharmacological rescue, primary cortical neuron morphology analysis\",\n      \"pmids\": [\"27423518\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which DAG/PA species mediate serotonergic effects not identified at this point\", \"Circuit-level localization of DGKδ-dependent serotonin changes not mapped\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"DGKδ was identified as a residential ER kinase that physically interacts with IFT88 and triggers COPII-dependent ER export of ciliary cargo, linking lipid kinase activity to ciliogenesis and Sonic hedgehog signaling.\",\n      \"evidence\": \"Co-IP of IFT88 with DGKδ, RNAi/KO with COPII vesicle and Shh reporter assays\",\n      \"pmids\": [\"28706295\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How PA production at ERES promotes COPII vesicle budding mechanistically unresolved\", \"Whether all ciliary cargo depends on DGKδ or only IFT88 not tested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"The mechanism of DGKδ-dependent SERT regulation was fully delineated: DGKδ recruits the Praja-1 E3 ligase via MAGE-D1 to promote SERT ubiquitination and proteasomal degradation in a catalytic activity-dependent manner, explaining the serotonergic hypofunction in brain-specific knockouts.\",\n      \"evidence\": \"Co-IP and domain mapping of DGKδ-SERT-Praja-1 complex, ubiquitination assay with kinase-dead mutant and proteasome inhibitor MG-132\",\n      \"pmids\": [\"31891772\", \"29486157\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo validation that Praja-1 mediates SERT turnover in DGKδ-KO brain not performed\", \"Quantitative contribution of SERT accumulation vs. reduced serotonin synthesis to behavioral phenotype not established\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Two discoveries connected DGKδ to specific lipid-protein signaling codes: in brain, DGKδ selectively produces 18:0/22:6-PA which activates Praja-1; in the ER, SMSr provides 16:0-containing DAG substrates via SAM-domain-mediated interaction, establishing tissue-specific upstream supply chains.\",\n      \"evidence\": \"KO brain lipidomics by LC-MS with PA-Praja-1 binding/activity assay; SMSr-DGKδ co-IP with SAM domain mutants and in vitro DGK activity reconstitution\",\n      \"pmids\": [\"32134507\", \"31980461\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SMSr-DGKδ axis operates in skeletal muscle not tested\", \"Structural basis of 18:0/22:6-PA recognition by Praja-1 unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"β-cell-specific knockout showed DGKδ suppresses pancreatic β-cell proliferation via cyclin B1 regulation, revealing a tissue where DGKδ loss is beneficial (improved glucose tolerance), contrasting with its pro-insulin-signaling role in muscle.\",\n      \"evidence\": \"β-cell-specific DGKδ KO mice with glucose tolerance tests, Ki-67/BrdU proliferation assays, cyclin B1 Western blot\",\n      \"pmids\": [\"33774855\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether proliferation effect is DAG- or PA-mediated not determined\", \"Long-term β-cell function and exhaustion risk not assessed\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"DGKδ protein stability was shown to be maintained by USP11 deubiquitinase, and conditional skeletal muscle knockout demonstrated DGKδ is required for satellite cell-mediated muscle regeneration and myofiber maintenance.\",\n      \"evidence\": \"USP11-DGKδ co-IP with domain mapping, ubiquitination assay ± USP11 inhibitor/siRNA, glucose uptake assay; Myf5-Cre DGKδ KO with cardiotoxin injury and myogenic marker analysis\",\n      \"pmids\": [\"39603461\", \"39781426\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether USP11 regulates DGKδ in tissues beyond the tested cell lines unknown\", \"Whether impaired regeneration is DAG/PKC-dependent or PA-dependent not tested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"DGKD missense variants associated with kidney stone disease impair CaSR signaling, rescued by cinacalcet, and PHOSPHO1 was identified as a candidate cytosolic PC-PLC providing saturated DAG substrates for DGKδ.\",\n      \"evidence\": \"Variant overexpression with CaSR signaling assay and cinacalcet rescue; PHOSPHO1 enzymatic assay and co-sedimentation with DGKδ\",\n      \"pmids\": [\"40372791\", \"39992810\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"PHOSPHO1-DGKδ physical interaction not validated by reciprocal co-IP\", \"Whether DGKD variants cause kidney stone disease through CaSR-independent mechanisms not excluded\", \"PHOSPHO1 contribution to DGKδ substrate pool not tested genetically\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of DGKδ substrate selectivity for saturated/monounsaturated DAGs, how PA production at ER exit sites mechanistically promotes COPII vesicle budding, and the relative contributions of DAG clearance versus PA generation to each tissue-specific phenotype.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal or cryo-EM structure of DGKδ catalytic domain\", \"No reconstituted system linking specific PA species to COPII coat assembly\", \"Tissue-specific interactome not systematically mapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 5, 13, 21, 22]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [13, 21, 22]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [2, 16]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 3, 5, 12]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1, 3]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [3, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 5, 6, 9, 11, 20, 26]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [13, 14, 22, 28]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [2, 7, 8, 16]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [19, 24]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [16, 18, 25]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [15, 17]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"AP2A1\",\n      \"IFT88\",\n      \"SLC6A4\",\n      \"PJA1\",\n      \"MAGED1\",\n      \"USP11\",\n      \"GNB2L1\",\n      \"SAMD8\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}